<code id='934B29B8DB'></code><style id='934B29B8DB'></style>
    • <acronym id='934B29B8DB'></acronym>
      <center id='934B29B8DB'><center id='934B29B8DB'><tfoot id='934B29B8DB'></tfoot></center><abbr id='934B29B8DB'><dir id='934B29B8DB'><tfoot id='934B29B8DB'></tfoot><noframes id='934B29B8DB'>

    • <optgroup id='934B29B8DB'><strike id='934B29B8DB'><sup id='934B29B8DB'></sup></strike><code id='934B29B8DB'></code></optgroup>
        1. <b id='934B29B8DB'><label id='934B29B8DB'><select id='934B29B8DB'><dt id='934B29B8DB'><span id='934B29B8DB'></span></dt></select></label></b><u id='934B29B8DB'></u>
          <i id='934B29B8DB'><strike id='934B29B8DB'><tt id='934B29B8DB'><pre id='934B29B8DB'></pre></tt></strike></i>

          knowledge

          knowledge

          author:knowledge    Page View:8219
          In this photo illustration, Farxiga, Xarelto, Entresto, and Eliquis are made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. These are 4 of 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act. The other drugs include Jardiance, Enbrel, Januvia, Imbruvica, Stelara and Fiasp.
          Scott Olson/Getty Images

          WASHINGTON  — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.

          The offers will not be made public unless a manufacturer chooses to publicly disclose information about the talks, a senior administration official said. Companies have until March 2 to either accept the government’s offer or propose a counteroffer. The Biden administration will publish the final prices by Sept. 1 of this year after the negotiation process ends. 

          advertisement

          The negotiated prices won’t take effect until 2026. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          The new HIV moral panic
          The new HIV moral panic

          Gilead'sPrEPpillTruvadaJustinSullivan/GettyImagesInMay,justbeforePrideMonth,theCentersforDiseaseCont

          read more
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

          6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

          read more

          Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

          0:53FILEPHOTO:ElonMusk,ChiefExecutiveOfficerofSpaceXandTeslaandownerofTwitter,gesturesasheattendsthe